Not Yet Recruiting
Efficacy and Safety of Brentuximab Vedotin Combined With Lisaftoclax in CD30+ Cutaneous T-cell Lymphoma (CTCL)
NCT07717580
- Conditions
- Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Peking University First Hospital Beijing, Beijing Municipality, China